Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Downgrades Interface to Hold, Lowers Price Target to $9

Truist Securities analyst Keith Hughes downgrades Interface (NASDAQ:TILE) from Buy to Hold and lowers the price target from $13 to $9.
byBenzinga Newsdesk
February 22, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Truist Securities analyst Keith Hughes downgrades Interface (NASDAQ:TILE) from Buy to Hold and lowers the price target from $13 to $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio

By Vandana Singh
August 1, 8:30 AM
Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of its overarching strategy to strengthen its IP portfolio further.

CMND